Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
pubmed-bpc157-gastric-pentadecapeptide-1993 BPC-157 protection against gastric and duodenal lesions in rat ulcer models Preclinical rat study by Sikiric and colleagues reporting BPC-157 was effective across restraint-stress, cysteamine, ethanol, indomethacin, and capsaicin ulcer models
Customer Data 3.1.1
Reviewing your weight loss attempts with your healthcare provider allows them to determine if medication is necessary or if other interventions can be attempted first
Lipotropic Injections: Do They Work for Weight Loss
Food Hydrocolloids (2018) 77:83442
